Business · 29/11/2018

FDA Announces Draft Guidance for Dual 510(k) and CLIA Waiver by Application Studies

The FDA is releasing a draft guidance that outlines study designs for generating data to support both 510(k) clearance and CLIA waiver for new in vitro diagnostic devices, aiming to streamline the process and bring simple, accurate devices to CLIA waived settings.